, Singapore
Photo by Edward Jenner from Pexels

CCCS holds public consultation on proposed TalkMed acquisition

The consultation will determine whether the acquisition by Tamarind Health would be anti-competitive.

The Competition and Consumer Commission of Singapore (CCCS) is inviting public feedback on the proposed acquisition of TalkMed Group by Tamarind Health Limited (THL).

Last 13 January, CCCS accepted a joint application from both companies for a decision on whether the transaction would be anti-competitive.

THL is active in medical oncology in Singapore. Outside of Singapore, THL’s activities include post-cancer, advisory and consultation services in Malaysia; medical and radiation oncology services in the Philippines, and oncology services in Hong Kong.

Meanwhile, TalkMed provides medical oncology services, adult and paediatric blood disorders treatment, haematologic malignancies and palliative healthcare services. The group also provides cellular and gene therapy-related products and services.

TW Troy Limited, an indirectly wholly-owned subsidiary of THL, will acquire all the issued and paid shares in TalkMed.

Public feedback can be submitted starting  21 January to 5:00 pm on 31 January.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!